The Medical Imaging & Technology Alliance challenged Medicare's limited coverage for beta-amyloid PET, used to help identify those at risk.

Specialties that provided fewer E/M services, such as radiology and general surgery, saw the largest declines, experts wrote in JAMA. 

The Susan G. Komen organization has lobbied for the proposals and recently touted them in a series of separate announcements. 

Some physicians believe recent guidance from the federal government will make the mechanism for settling payment disputes with insurers “economically infeasible."

Mammography screening trends had remained flat, but they fell across all age groups after the USPSTF issued new guidelines in 2009.

CMS first announced the change late last year via the 2023 Outpatient Prospective Payment System/Ambulatory Surgical Center Final Rule. 

A cancer treatment product developed by Merit Medical Systems of South Jordan, Utah, has been designated a breakthrough device by the FDA.

The FDA alerted patients and providers about the issue Feb. 15, labeling it as the agency’s “most serious” type of recall.